Regeneron Pharmaceuticals REGN

By Kapitall : Do you follow company sales trends? Most companies rely on sales as their primary source of profits, so a sales analysis should be high on the list. To illustrate, we ran a screen. We began by screening the biotech industry for stocks with high growth prospects, with 5-year projected

… 45.12) First Trust Arca Biotechnology Index Fund is up 38% YTD riding some big winners like Amylin ( AMLN ) Regeneron ( REGN ) and Vertex ( VRTX ). Recently Benziga published an article on biotech ETF's reiterating the underlying basis for strength …

By Prohost Biotech : The time has come for redefining the meaning of “creating shareholder value” in the biotech sector. Pinpointing the real value has become imperative. It is the road to a fair assessment of innovative biotech firms. It helps investors reap the fruits of the real value of ...

By Jessica King Holden : The biotech sector attracts a certain type of investor, one that is often not afraid of a little educated speculation in the stock market. In horse racing, a good wager involves investigating a horse's race history, its physical attributes, its unique talents, its training

… buying or selling represents a strong pick-up based on historical buying and selling in the stock (for more info on how to interpret insider trades, please refer to the end of this article): Regeneron Pharmaceutical ( REGN Complete Story »

By Spencer Knight : As a rocky month of April comes to a close, the month of May looks to be very exciting for the Healthcare and Biotech sectors. There are 14 events scheduled for May, including a few very high profile treatments. Healthcare and particularly biotech trading can be very lucrative

… 2012 the year of the biotech resurgence, but it is tempting. There are the solid success stories like that of Regeneron's ( REGN ) Eylea launch and its stock up over 150% YTD. Next, there is the excited speculation over progress and approval of obesity …